miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) lacks both early detection biomarkers and viable targeted therapeutics. Moreover, chemotherapy only produces 20–30% pathologic complete response. Because miRNAs are frequently dysregulated in breast cancer and have broad tissue effects, individual or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Li, Hao-Yi, Liang, Jui-Lin, Kuo, Yao-Lung, Lee, Hao-Hsien, Calkins, Marcus J., Chang, Hong-Tai, Lin, Forn-Chia, Chen, Yu-Chia, Hsu, Tai-I, Hsiao, Michael, Ger, Luo-Ping, Lu, Pei-Jung
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738224/
https://ncbi.nlm.nih.gov/pubmed/29258605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-017-0918-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados